The BARD1 Cys557Ser variant and breast cancer risk in Iceland - Wikidata - awgldk - TriplyDB

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

http://www.wikidata.org/entity/Q33246499

about

The impact of divergence time on the nature of population structure: an example from Iceland Common variations in BARD1 influence susceptibility to high-risk neuroblastoma Crystal Structure of the BARD1 Ankyrin Repeat Domain and Its Functional Consequences Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility.Automatically classifying the role of citations in biomedical articles.Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.CDKN2A mutations and melanoma risk in the Icelandic population.Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis.Global distribution of fatal familial insomnia: founder or recurrent mutations.Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.Dualistic Role of BARD1 in Cancer.Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.Cancer risk assessment using genetic panel testing: considerations for clinical application.

P2860

Q21090210-5F79817B-3DA6-4531-9F5D-106D873C24E2 Q24645352-3050B8B6-6E0C-4AB0-AB40-98611D26F0E1 Q27650617-74EB8F9D-6C24-4A95-B9DC-D634D170BBF5 Q30000832-F06625FB-ECC5-44A1-9BCC-91A3D5527B26 Q33809764-2576D414-C4A4-4DE8-9169-937B8C50B0BE Q33828049-863B584D-DE30-4D43-98D5-9472D69F8534 Q34949394-D18CACCD-DC39-4F7B-A0B9-426BEA2750A5 Q35609672-0E127E56-64ED-4E8F-9D06-D06C31B6F33D Q35631708-33F12391-306B-44E3-87F9-B68DF1512882 Q35737508-CBE5C430-174E-431D-9843-50F5008134EF Q36101775-D4FE7E59-9F53-448A-B280-DDE7B7A8CC32 Q36610631-EB5A13CB-F3D7-4ED8-A8A3-4BDF549E9028 Q36664974-A666379F-E684-4704-9F34-C1F98A1F52F8 Q36974076-CC59D8DF-17B9-467B-87F8-2C73799E1005 Q38912904-6A2A3D3C-9C13-4719-AFD3-8A8924043C2E Q47177315-1D7877E7-4F3C-4764-AA51-F2BC0A78BD8D Q51837133-600687B6-9FFC-4BC9-910C-94977A7EBF99 Q53292592-7B57AE6B-EDCC-43E5-9502-D35584F50060

P2860

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

http://www.wikidata.org/entity/Q33246499

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@ast

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@en

type

label

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@ast

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@en

prefLabel

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@ast

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@en

P1433

Q33246499-BCDD394C-80D1-4F90-8513-DAEEA66B7AF8

P1476

Q33246499-C8D85849-CD4D-4C1B-8647-7F2ADF05DFB5

P2093

Q33246499-295F0A9C-D332-4D0B-B987-41E8A2F9376E

Q33246499-2EB40788-6B13-4426-98EE-E33D1CCB330F

Q33246499-2FFBFD95-757A-4361-8EBE-3C44A165441C

Q33246499-3CB7BBCD-4FC1-4674-AB4D-F51A2841B3BB

Q33246499-6A6F10DA-89EE-428A-BE61-68843732574F

Q33246499-7A4A9AEC-AD33-4AAA-BBA6-F4C4661DF690

Q33246499-7FF7EDC8-E8AC-4F43-996C-0D4E37D2CD9C

Q33246499-8067E3EB-AD65-439D-BDC7-7FAA715B03CA

Q33246499-9755AC93-5046-4946-9ED4-5E037EB48495

Q33246499-C009E458-0E7E-493D-B8DD-AB11BACFF9E5

P2860

Q33246499-0143260F-838B-4C10-ADBC-17FFA8C238B3

Q33246499-0B07AEA6-B7CA-4A75-80A0-3D91835D104F

Q33246499-0E44C055-E9E5-49B8-8503-EF933425102E

Q33246499-169C4CAB-8D50-44F7-AC3E-FE91ACB86CC7

Q33246499-1B0F1047-63BA-4CAD-8038-55654C796169

Q33246499-233CFE08-D10A-4403-86F9-899B5FC7ADB7

Q33246499-2357D0D8-6C93-4124-8F86-1755D16CA981

Q33246499-236B10D4-AADC-4FA6-9193-CF36AB3EF6DB

Q33246499-2EF5F3AC-BDBD-4670-BC70-C24E48430297

Q33246499-2F8EFAE3-CDE3-49AC-B9BE-FEC4D2C191B6

P304

Q33246499-62B7DE90-2774-429F-9E8A-F21FD1790810

P31

Q33246499-060D5237-B4F1-46E3-9569-919A3F961EE8

P356

Q33246499-BDEEB5CF-9E15-45E8-8047-E8ECA51B8F53

P407

Q33246499-BDE881A1-89CE-4FAD-B93C-CFD622C1B817

P433

Q33246499-069EA245-2ED1-4767-815E-8CEB3D7286F6

P478

Q33246499-EAA1CF26-4433-4781-A6FF-A66D9CDF5ED5

P50

Q33246499-1D8611F4-F2F1-4E24-8233-E4439106662A

Q33246499-42854A32-8B3B-43AB-947C-2C361E7FEDB0

Q33246499-6D32276B-D7D9-49FB-944F-E8DADCE29306

Q33246499-B878F79E-19FB-4AD9-A075-8347DF1D66F4

Q33246499-CFECFFA6-D7A9-4889-87D5-99590BC9E70B

Q33246499-EAB346F4-C659-4B2A-8DFB-6657C080A2D3

P577

Q33246499-78DFF6FE-60F5-4DA6-A30D-C35C075D1E90

P5875

Q33246499-FB69C7AE-DC0E-4121-81B0-DCB92C046B2D

P698

Q33246499-4F342750-1940-4928-A4E3-0E9531031585

P921

Q33246499-DA1C319E-672E-47A9-81FF-E9803371E932

P932

Q33246499-2EECC3AF-171A-428A-A2AB-EF157931D2F6

P356

JOURNAL.PMED.0030217

P1433

P1476

The BARD1 Cys557Ser variant and breast cancer risk in Iceland

@en

P2093

Agnar Helgason

http://www.w3.org/2001/XMLSchema#string

Gardar Myrdal

http://www.w3.org/2001/XMLSchema#string

Helgi Sigurdsson

http://www.w3.org/2001/XMLSchema#string

Hlynur Niels Grimsson

http://www.w3.org/2001/XMLSchema#string

Jakob Johannsson

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Gulcher

http://www.w3.org/2001/XMLSchema#string

Jelena P Kostic

http://www.w3.org/2001/XMLSchema#string

Jon Hrafnkelsson

http://www.w3.org/2001/XMLSchema#string

Julius Gudmundsson

http://www.w3.org/2001/XMLSchema#string

Kristleifur Kristjansson

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention

The mutation rate in the human mtDNA control region

Study of a single BRCA2 mutation with high carrier frequency in a small population

The pathology of familial breast cancer: Morphological aspects.

How many more breast cancer predisposition genes are there?

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1

The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression

P304

e217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.0030217

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Unnur Þorsteinsdóttir

Laufey T. Amundadottir

Jon T Bergthorsson

Kári Stefánsson

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7014124

http://www.w3.org/2001/XMLSchema#string

P698

16768547

http://www.w3.org/2001/XMLSchema#string

P921

P932

1479388

http://www.w3.org/2001/XMLSchema#string